We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

This week's business roundup also includes promotions, Missouri manufacturing hall of fame inductees and a public mural ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

Medical industry giants Eli Lilly and Merck will collaborate with Purdue through a new institute, which aims to advance ...

On Nov. 22, 1963, 36-year-old Eddie Barker was the first man in the world to deliver news on the television that would change ...

Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical giant, currently ...

Redevelopment of a former mall, the replacement of a freeway, more hotel rooms and housing are all on the table for ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Some of the larger M&A deals of 2024 were Eli Lilly’s buyout ... driven by the launch of new products and contributions from Abiomed and Shockwave acquisitions. The company also has an ...

In its motion filed on New Year’s Day ... capacity.” The company also said it seeks to intervene because it does not believe the FDA adequately represents Eli Lilly’s interests.

shares edged around 0.7% lower Tuesday as the company announced a price cut for its obesity drug Zepbound. The new single-dose vials, available in 2.5 mg and 5... Tuesday, Eli Lilly (NYSE ...